The Innovative Medicines Initiative (IMI) is a joint undertaking between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA), a public-private partnership aiming to improve the drug development process by supporting a more efficient discovery and development of better and safer medicines for patients.

The QuIC-ConCePT (Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy) project is an IMI funded project which aims to provide drug developers with tools, imaging biomarkers, that can show earlier and more accurately how patients’ tumors respond to drugs in cancer clinical trials.

The QuIC-ConCePT consortium has 14 academic, one SME (small – medium sized enterprises) and eight EFPIA partners and is coordinated by AstraZeneca and managed by the European Organisation for Research and Treatment of Cancer (EORTC).

IMI oncology projects